- Home
- GROW vs ECOR Comparison
GROW vs ECOR Comparison
Compare GROW & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROW
- ECOR
- Stock Information
- Founded
- GROW 1968
- ECOR 2005
- Country
- GROW United States
- ECOR United States
- Employees
- GROW N/A
- ECOR N/A
- Industry
- GROW Investment Managers
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GROW Finance
- ECOR Health Care
- Exchange
- GROW Nasdaq
- ECOR Nasdaq
- Market Cap
- GROW 32.2M
- ECOR 37.1M
- IPO Year
- GROW N/A
- ECOR 2018
- Fundamental
- Price
- GROW $2.48
- ECOR $4.83
- Analyst Decision
- GROW
- ECOR Strong Buy
- Analyst Count
- GROW 0
- ECOR 2
- Target Price
- GROW N/A
- ECOR $25.50
- AVG Volume (30 Days)
- GROW 17.1K
- ECOR 62.4K
- Earning Date
- GROW 09-08-2025
- ECOR 11-12-2025
- Dividend Yield
- GROW 3.64%
- ECOR N/A
- EPS Growth
- GROW N/A
- ECOR N/A
- EPS
- GROW N/A
- ECOR N/A
- Revenue
- GROW $8,452,000.00
- ECOR $27,700,000.00
- Revenue This Year
- GROW N/A
- ECOR $24.48
- Revenue Next Year
- GROW N/A
- ECOR $44.35
- P/E Ratio
- GROW N/A
- ECOR N/A
- Revenue Growth
- GROW N/A
- ECOR 30.16
- 52 Week Low
- GROW $2.02
- ECOR $4.16
- 52 Week High
- GROW $2.68
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- GROW 54.92
- ECOR 41.17
- Support Level
- GROW $2.39
- ECOR $4.70
- Resistance Level
- GROW $2.52
- ECOR $5.25
- Average True Range (ATR)
- GROW 0.06
- ECOR 0.26
- MACD
- GROW 0.00
- ECOR 0.01
- Stochastic Oscillator
- GROW 72.31
- ECOR 13.00
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.